Skip to main content
Top
Published in: Critical Care 1/2006

01-02-2005 | Commentary

Contemporary management of infected necrosis complicating severe acute pancreatitis

Authors: Saurabh Jamdar, Ajith K Siriwardena

Published in: Critical Care | Issue 1/2006

Login to get access

Abstract

Pancreatic necrosis complicating severe acute pancreatitis is a challenging scenario in contemporary critical care practice; it requires multidisciplinary care in a setting where there is a relatively limited evidence base to support decision making. This commentary provides a concise overview of current management of patients with infected necrosis, focusing on detection, the role of pharmacologic intervention, and the timing and nature of surgical interventions. Fine-needle aspiration of necrosis remains the mainstay for establishment of infection. Pharmacological intervention includes antibiotic therapy as an adjunct to surgical debridement/drainage and, more recently, drotrecogin alfa. Specific concerns remain regarding the suitability of drotrecogin alfa in this setting. Early surgical intervention is unhelpful; surgery is indicated when there is strong evidence for infection of necrotic tissue, with the current trend being toward 'less drastic' surgical interventions.
Literature
1.
go back to reference Beattie GC, Mason J, Swan D, Madhavan KK, Siriwardena AK: Outcome of necrosectomy in acute pancreatitis: the case for continued vigilance. Scand J Gastroenterol 2002, 37: 1449-1453. 10.1080/003655202762671341CrossRefPubMed Beattie GC, Mason J, Swan D, Madhavan KK, Siriwardena AK: Outcome of necrosectomy in acute pancreatitis: the case for continued vigilance. Scand J Gastroenterol 2002, 37: 1449-1453. 10.1080/003655202762671341CrossRefPubMed
2.
go back to reference Fenton-Lee D, Imrie CW: Pancreatic necrosis: assessment of outcome related to quality of life and cost of management. Br J Surg 1993, 80: 1579-1582.CrossRefPubMed Fenton-Lee D, Imrie CW: Pancreatic necrosis: assessment of outcome related to quality of life and cost of management. Br J Surg 1993, 80: 1579-1582.CrossRefPubMed
3.
go back to reference McKay CJ, Imrie CW: The continuing challenge of early mortality in acute pancreatitis. Br J Surg 2004, 91: 1243-1244. 10.1002/bjs.4750CrossRefPubMed McKay CJ, Imrie CW: The continuing challenge of early mortality in acute pancreatitis. Br J Surg 2004, 91: 1243-1244. 10.1002/bjs.4750CrossRefPubMed
4.
go back to reference Ashley SW, Perez A, Pierce EA, Brooks DC, Moore FD, Whang EE, Banks PA, Zinner MJ: Necrotizing pancreatitis. Contemporary analysis of 99 consecutive cases. Ann Surg 2001, 234: 572-579. 10.1097/00000658-200110000-00016PubMedCentralCrossRefPubMed Ashley SW, Perez A, Pierce EA, Brooks DC, Moore FD, Whang EE, Banks PA, Zinner MJ: Necrotizing pancreatitis. Contemporary analysis of 99 consecutive cases. Ann Surg 2001, 234: 572-579. 10.1097/00000658-200110000-00016PubMedCentralCrossRefPubMed
5.
go back to reference Beger HG, Bittner R, Block S, Buchler M: Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986, 91: 433-438.PubMed Beger HG, Bittner R, Block S, Buchler M: Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986, 91: 433-438.PubMed
6.
go back to reference Al-Bahrani A, Ammori BJ: Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta 2005, 362: 26-48. 10.1016/j.cccn.2005.06.008CrossRefPubMed Al-Bahrani A, Ammori BJ: Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta 2005, 362: 26-48. 10.1016/j.cccn.2005.06.008CrossRefPubMed
7.
go back to reference Ammori BJ, Fitzgerald P, Hawkey P, McMahon MJ: The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas 2003, 26: 18-22. 10.1097/00006676-200301000-00004CrossRefPubMed Ammori BJ, Fitzgerald P, Hawkey P, McMahon MJ: The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas 2003, 26: 18-22. 10.1097/00006676-200301000-00004CrossRefPubMed
8.
go back to reference Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed
9.
go back to reference Yamanel L, Mas MR, Comert B, Isik AT, Aydin S, Mas N, Deveci S, Ozyurt M, Tasci I, Unal T: The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care 2005, 9: 184-190. 10.1186/cc3485CrossRef Yamanel L, Mas MR, Comert B, Isik AT, Aydin S, Mas N, Deveci S, Ozyurt M, Tasci I, Unal T: The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care 2005, 9: 184-190. 10.1186/cc3485CrossRef
10.
go back to reference Jamdar S, Siriwardena AK: Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis. Crit Care 2005, 9: 321-322. 10.1186/cc3777PubMedCentralCrossRefPubMed Jamdar S, Siriwardena AK: Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis. Crit Care 2005, 9: 321-322. 10.1186/cc3777PubMedCentralCrossRefPubMed
13.
go back to reference Mier J, Leon EL, Castillo A, Robledo F, Blanco R: Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 1997, 173: 71-75. 10.1016/S0002-9610(96)00425-4CrossRefPubMed Mier J, Leon EL, Castillo A, Robledo F, Blanco R: Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 1997, 173: 71-75. 10.1016/S0002-9610(96)00425-4CrossRefPubMed
14.
go back to reference Tao HQ, Zhang JX, Zou SC: Clinical characteristics and management of patients with early severe pancreatitis: experience from a medical center in China. World J Gastroenterol 2004, 10: 919-921.PubMed Tao HQ, Zhang JX, Zou SC: Clinical characteristics and management of patients with early severe pancreatitis: experience from a medical center in China. World J Gastroenterol 2004, 10: 919-921.PubMed
15.
go back to reference De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F: Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005, 9: 452-457. 10.1186/cc3754CrossRef De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F: Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005, 9: 452-457. 10.1186/cc3754CrossRef
16.
go back to reference Leppaniemi A, Kemppainen E: Recent advances in the surgical management of necrotizing pancreatitis. Curr Opin Crit Care 2005, 11: 349-352. 10.1097/01.ccx.0000166398.50517.fbCrossRefPubMed Leppaniemi A, Kemppainen E: Recent advances in the surgical management of necrotizing pancreatitis. Curr Opin Crit Care 2005, 11: 349-352. 10.1097/01.ccx.0000166398.50517.fbCrossRefPubMed
17.
go back to reference Carter CR, McKay CJ, Imrie CW: Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg 2000, 232: 175-180. 10.1097/00000658-200008000-00004PubMedCentralCrossRefPubMed Carter CR, McKay CJ, Imrie CW: Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg 2000, 232: 175-180. 10.1097/00000658-200008000-00004PubMedCentralCrossRefPubMed
18.
go back to reference Virlos IT, Mason J, Schofield D, McCloy RF, Eddleston JM, Siriwardena AK: Intravenous n-actylcysteine, ascorbic acid and selenium-based anti-oxidant therapy in severe acute pancreatitis. Scand J Gastroenterol 2003, 38: 1262-1267. 10.1080/00365520310006540CrossRefPubMed Virlos IT, Mason J, Schofield D, McCloy RF, Eddleston JM, Siriwardena AK: Intravenous n-actylcysteine, ascorbic acid and selenium-based anti-oxidant therapy in severe acute pancreatitis. Scand J Gastroenterol 2003, 38: 1262-1267. 10.1080/00365520310006540CrossRefPubMed
Metadata
Title
Contemporary management of infected necrosis complicating severe acute pancreatitis
Authors
Saurabh Jamdar
Ajith K Siriwardena
Publication date
01-02-2005
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2006
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc3928

Other articles of this Issue 1/2006

Critical Care 1/2006 Go to the issue